ClinicalTrials.Veeva

Menu

Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Unknown

Conditions

Thromboembolism
Acute Lymphoblastic Leukemia

Study type

Observational

Funder types

Other

Identifiers

NCT00982514
ASP NOPHO 2008

Details and patient eligibility

About

The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study clinical symptomatic thromboses, asymptomatic central line-associated thromboses, and infections.

Enrollment

60 estimated patients

Sex

All

Ages

1 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute lymphoblastic leukaemia,
  • Age 1 year to 16 years old,
  • Central line,
  • Protocol NOPHO ALL 2008.

Exclusion criteria

  • Refusal of participation,
  • Treated according to protocol other than NOPHO ALL 2008.

Trial design

60 participants in 2 patient groups

Standard dose asparaginase
Description:
Children who according to the protocol NOPHO ALL 2008 receive standard dose asparaginase
Reduced dose asparaginase
Description:
Children who receive reduced dose asparaginase according to NOPHO ALL 2008

Trial contacts and locations

1

Loading...

Central trial contact

Tonje Reiersen, MD; Ellen Ruud, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems